Symptom questionnaire
The Four-Dimensional Symptom Questionnaire (4DSQ) in the general population: scale structure, reliability, measurement invariance and normative data: a cross-sectional survey
16
The Four Dimensional Symptom Questionnaire (4DSQ): a validation study of a multidimensional self report questionnaire to assess distress, depression, anxiety and somatization
20
Clinical utility of the Mood and Anxiety Symptom Questionnaire (MASQ) in a sample of young help seekers
7
To what extent does the anxiety scale of the Four Dimensional Symptom Questionnaire (4DSQ) detect specific types of anxiety disorder in primary care? A psychometric study
15
Factor Analysis of the DePaul Symptom Questionnaire: Identifying Core Domains
9
Evaluation of the Birmingham IBS symptom questionnaire
7
Psychometric validation of the Dysphagia Symptom Questionnaire in patients with eosinophilic esophagitis treated with budesonide oral suspension
11
Development and initial validation of a traditional Chinese medicine symptom-specific outcome measure: a Zheng-related atopic dermatitis symptom questionnaire (ZRADSQ)
9
Patient-reported outcome measures: selection of a valid questionnaire for routine symptom assessment in patients with advanced chronic kidney disease – a four-phase mixed methods study
11
Development and validation of a new Arrhythmia-Specific questionnaire in Tachycardia and Arrhythmia (ASTA) with focus on symptom burden
10
Atrial Fibrillation Symptom Clusters
115
Symptom Proximity in Diagnostic Problem
10
Incontinence as a symptom of prostate problems
10
PAIN & SYMPTOM CONTROL GUIDELINES
252
Unintentional Symptom Intensification by Doctors
5
PICA—SYMPTOM OR VESTIGIAL INSTINCT?
6
Symptom burden among patients with Renal Cell Carcinoma (RCC): content for a symptom index
12
Symptoms and markers of symptom severity in asthma—content validity of the asthma symptom diary
9
The child with a limp: a symptom and not a diagnosis
27
Construct validity of symptom checklist 90 revised (SCL 90 R) and general health questionnaire 28 (GHQ 28) in patients with drug addiction and diabetes, and normal population
9